キーワード:
乳がん, Mammakarzinom, Brustkrebs, Mammatumor, "mammary carcinoma", "breast carcinoma", "breast cancer", "mammary tumor", 乳腺腫瘍
-
FASEB J 6 (11): 3016-3017
-
1992,
Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW
FASEB J 6 (3): 853-860
-
1979,
Myers PC, Sadowsky NL, Barrett AH
J Microw Power 14 (2): 105-114
-
J Microw Power 14 (2): 155-158
-
J Microw Power 14 (2): 95-104
-
1976,
Robinson JE, McCulloch D, Edelsack EA
J Microw Power 11 (2): 87-98
-
Lancet 339 (8807): 1482-1483
-
1991,
Matanoski GM, Breysse PN, Elliott EA
Lancet 337 (8743): 737
-
1990,
Tynes T, Andersen A
Lancet 336 (8730): 1596
-
1999,
Boorman GA, McCormick DL, Findlay JC, Hailey JR, Gauger JR, Johnson TR, Kovatch RM, Sills RC, Haseman JK
Toxicol Pathol 27 (3): 267-278
-
1999,
McCormick DL, Boorman GA, Findlay JC, Hailey JR, Johnson TR, Gauger JR, Pletcher JM, Sills RC, Haseman JK
Toxicol Pathol 27 (3): 279-285
-
2020,
Abusoglu G, Ozturk B
Turk J Biochem 45 (6): 833-841
-
Umwelt · Medizin · Gesellschaft 22 (1): 55-60
-
2006,
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M
[詳細]
[携帯電話中継局とがん発生率]
[epidem.]
Umweltmed Forsch Prax 11 (2): 89-97
-
2004,
Silny J, Meyer M, Wiesmüller GA, Dott W
Umweltmed Forsch Prax 9 (2): 127-136
-
2001,
Schüz J, Michaelis J
[詳細]
[非電離放射線の疫学:概要]
[review]
Umweltmed Forsch Prax 6 (2): 67-76
-
Adv Gerontol 23 (4): 554-556
-
2022,
Evstigneeva IS, Gerasimenko MY
Vopr Kurortol Fizioter Lech Fiz Kult 99 (4): 43-50
-
2021,
Kochetkova NA, Kulikov AG
Vopr Kurortol Fizioter Lech Fiz Kult 98 (4): 11-17
-
2020,
Gerasimenko MY, Evstigneyeva IS, Zaitseva TN
Vopr Kurortol Fizioter Lech Fiz Kult 97 (2): 36-44
-
2004,
Zlatnik EI, Zakora GI, Starzhetskaia MV
Vopr Onkol 50 (1): 50-54
-
1993,
Beniashvili DS, Bulanishvili VG, Menabde MZ, Gupta D, Anisimov VN
Vopr Onkol 39 (1-3): 52-60
-
1991,
Beniashvili DSh, Bilanishvili VG, Menabde MZ
Vopr Onkol 37 (9-10): 937-941
-
2006,
Shen YH, Yu D, Fu YT, Chiang H
Zhonghua Yu Fang Yi Xue Za Zhi 40 (3): 164-167
-
2006,
Zeng QL, Weng Y, Chen GD, Lu DQ, Chiang H, Xu ZP
Zhonghua Yu Fang Yi Xue Za Zhi 40 (3): 153-158